Newomics

Developer of a biotechnology platform designed to create multi-omics diagnostic assays for diabetes, Alzheimer’s, and other diseases. The company’s platform offers proteomics, metabolomics, and lipidomics analyses of small amounts of biological samples, including human plasma and mammalian cells, enabling doctors to empower mass spectrometry through integration and miniaturization.